Citations Appearing in 2020

  1. Abebe, B.T., Weiss, M., Modess, C., Tadken, T., Wegner, D., Meyer, M.J., Schwantes, U., Neumeister, C., Scheuch, E., Schulz, H.U. and Tzvetkov, M., 2020. Pharmacokinetic Drug‐Drug Interactions Between Trospium Chloride and Ranitidine Substrates of Organic Cation Transporters in Healthy Human Subjects. The Journal of Clinical Pharmacology, 60(3), pp.312-323.
  2. Abebe, B.T., 2020. In Vitro to In Vivo Extrapolation of Pharmacokinetic Drug Interactions between Clarithromycin and Ranitidine with Trospium Chloride to Evaluate Probe Drug Characteristics for P-glycoprotein and Organic Cation Transporter Functions in Human.
  3. Aldroubi, A., Basser, P. and Vieira, N., 2020. Optimal sampling for the determination of calcium metabolism. Kinetic Models of Trace Element and Mineral Metabolism During Development, p.28.
  4. Annisa, V., 2020. Dasar-Dasar Pendekatan Analisis Data Biofarmasetika Berbasis PopulasJurnal Inovasi Farmasi Indonesia (JAFI), 2(1), pp. 1-10.
  5. Balyan, R., Dong, M., Pilipenko, V., Geisler, K., Vinks, A.A. and Chidambaran, V., 2020. Hydromorphone population pharmacokinetics in pediatric surgical patients. Anaesthesia Critical Care & Pain Medicine, 39(1), pp.87-109.
  6. Boidin, C., Moshiri, P., Dahyot-Fizelier, C., Goutelle, S. and Lefeuvre, S., 2020. Pharmacokinetic variability of beta-lactams in critically ill patients: A narrative review. Pediatric Anesthesia.
  7. Bhuyan, S., Felgner, S., Kocijancic, D. and Pawar, V., 2020. Pharmacodynamic Evaluation: Infectious Diseases. Drug Discovery and Evaluation: Methods in Clinical Pharmacology, pp.325-342.
  8. Bussing, D. and Shah, D.K., 2020. Development of a physiologically-based pharmacokinetic model for ocular disposition of monoclonal antibodies in rabbits. Journal of Pharmacokinetics and Pharmacodynamics, pp.1-16.
  9. Cáceres Guido, P., Humberto Pavan, C., Otamendi, E. and Bramuglia, G.F., 2020. Principios de estadística Bayesiana y su relación con la farmacocinética aplicada. Revista chilena de pediatría, 91(5), pp.828-837.
  10. Chan, K., Ledesma, K.R., Wang, W. and Tam, V.H., 2020. Characterization of Amikacin Drug Exposure and Nephrotoxicity in an Animal Model. Antimicrobial agents and chemotherapy, 64(9).
  11. Chan, K., Ledesma, K.R., Wang, W. and Tam, V.H., 2020. A robust LC–MS/MS method for amikacin: application to cellular uptake and pharmacokinetic studies. Bioanalysis, 12(7), pp.445-454.
  12. Chapagain, M., Gumbo, T., Heysell, S.K. and Srivastava, S., 2020. Comparison of a Novel Regimen of Rifapentine, Tedizolid, and Minocycline with Standard Regimens for Treatment of Pulmonary Mycobacterium kansasii. Antimicrobial Agents and Chemotherapy, 64(10).
  13. Campagne, O., Davis, A., Maharaj, A.R., Zhong, B., Stripay, J., Farmer, D., Roussel, M.F. and Stewart, C.F., 2020. CNS penetration and pharmacodynamics of the CHK1 inhibitor prexasertib in a mouse Group 3 medulloblastoma model. European Journal of Pharmaceutical Sciences, 142s, pp.105-106.
  14. Chen, W., Boras, B., Sung, T., Hu, W., Spilker, M.E. and D’Argenio, D.Z., 2020. Predicting Chemotherapy-Induced Neutropenia and Granulocyte Colony–Stimulating Factor Response Using Model-Based In Vitro to Clinical Translation. The AAPS journal, 22(6), pp.1-14.
  15. Chen, R.S., Sheu, S.Y., Wang, C.Y., Kuo, C.W., Wang, J.H., Kuo, T.F. and Chou, C.H., 2020. Plasma and Tissue Depletion of Oxolinic Acid after Administration to Orange-Spotted Grouper (Epinephelus coioides), Snubnose Pompano (Trachinotus blochii) and Giant Seaperch (Lates calcarifer). The Israeli Journal of Aquaculture-Bamidgeh. 72
  16. Chen, W., Boras, B., Sung, T., Yu, Y., Zheng, J., Wang, D., Hu, W., Spilker, M.E. and D’Argenio, D.Z., 2020. A physiological model of granulopoiesis to predict clinical drug induced neutropenia from in vitro bone marrow studies: with application to a cell cycle inhibitor. Journal of pharmacokinetics and pharmacodynamics, pp.1-20.
  17. Chen, W., Boras, B., Sung, T., Hu, W., Spilker, M.E. and D’Argenio, D.Z., 2020. Predicting Chemotherapy-Induced Neutropenia and Granulocyte Colony–Stimulating Factor Response Using Model-Based In Vitro to Clinical Translation. The AAPS journal, 22(6), pp.1-14.
  18. Chen, W., D’Argenio, D.Z., Sipos, A., Kim, K.J. and Crandall, E.D., 2020. Biokinetic Modeling of Nanoparticle Interactions with Lung Alveolar Epithelial Cells: Uptake, Intracellular Processing and Egress. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.
  19. Dalton, B.R., Rajakumar, I., Langevin, A., Ondro, C., Sabuda, D., Griener, T.P., Dersch-Mills, D. and Rennert-May, E., 2020. Vancomycin area under the curve to minimum inhibitory concentration ratio predicting clinical outcome: a systematic review and meta-analysis with pooled sensitivity and specificity. Clinical Microbiology and Infection, 26(4), pp.436-446.
  20. Das, S., Johnson, A., McEntee, L., Farrington, N., Kirby, A., Unsworth, J., Jimenez-Valverde, A., Kolamunnage-Dona, R., Bousquet, J., Alibaud, L. and Sable, C., 2020. Pharmacodynamics of the novel metallo-β-lactamase inhibitor ANT2681 in combination with meropenem for the treatment of infections caused by NDM-producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy, 64(11).
  21. Ding, H., Altai, M., Yin, W., Lindbo, S., Liu, H., Garousi, J., Xu, T., Orlova, A., Tolmachev, V., Hober, S. and Gräslund, T., 2020. HER2-specific pseudomonas exotoxin A PE25 based fusions: influence of targeting domain on target binding, toxicity, and in vivo biodistribution. Pharmaceutics, 12(4), p. 391.
  22. Drusano, G.L., Duncanson, B., Scanga, C.A., Kim, S., Schmidt, S., Neely, M.N., Yamada, W.M., Vicchiarelli, M., Peloquin, C.A. and Louie, A., 2020. Developing New Drugs for Mycobacterium tuberculosis Therapy: What Information Do We Get from Preclinical Animal Models?. Antimicrobial Agents and Chemotherapy, 64(12).
  23. Franchetti, Y., Nolin, T.D. and Franchetti, F., 2020. Indirect Measurement of Hepatic Drug Clearance by Fitting Dynamical Models.  arXiv preprint arXiv.
  24. Gergs, U., Becker, L., Okoniewski, R., Weiss, M., Delank, K.S. and Neumann, J., 2020. Population pharmacokinetics of cefuroxime and uptake into hip and spine bone of patients undergoing orthopaedic surgery. Journal of Pharmacy and Pharmacology, 72(3), pp. 364-370.
  25. Gibson, E.G., Davis, A., Zhong, B., Campagne, O., Roussel, M.F. and Stewart, C.F., 2020. Characterization of gemcitabine triphosphate formation in mice to aid in the development of a translational tumor model.  Cancer Research, 80 (16_Supplement), pp. 3031-3031.
  26. Glassman, P.M. and Muzykantov, V.R., 2020. Target-mediated exposure enhancement: a previously unexplored limit of TMDD. Journal of pharmacokinetics and pharmacodynamics, 47(5), pp. 411-420.
  27. Guan, X. and Morris, M.E., 2020. In Vitro and In Vivo Efficacy of AZD3965 and Alpha-Cyano-4-Hydroxycinnamic Acid in the Murine 4T1 Breast Tumor Model. The AAPS Journal, 22(4), pp. 1-11.
  28. Hack, C.E., Efremenko, A.Y., Pendse, S.N., Ellison, C.A., Najjar, A., Hewitt, N., Schepky, A. and Clewell III, H.J., 2020. Physiologically based pharmacokinetic modeling software. In Physiologically Based Pharmacokinetic (PBPK) Modeling (pp. 81-126)., Academic Press.
  29. Hao, K., 2020. Modeling disease progression in newly diagnosed type 2 diabetes. bioRxiv.
  30. Haas, D.W., Podany, A.T., Bao, Y., Swindells, S., Chaisson, R.E., Mwelase, N., Supparatpinyo, K., Mohapi, L., Gupta, A., Benson, C.A. and Baker, P., 2020. Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine.  Pharmacogenetics and Genomics, 31(1), pp. 17-27.
  31. He, N., Dong, F., Liu, W. and Zhai, S., 2020. A Systematic Review of Vancomycin Dosing in Patients with Hematologic Malignancies or Neutropenia. Infection and Drug Resistance, 13, p. 1807.
  32. Holleran, J.L., Parise, R.A., Guo, J., Kiesel, B.F., Taylor, S.E., Ivy, S.P., Chu, E. and Beumer, J.H., 2020. Quantitation of iohexol, a glomerular filtration marker, in human plasma by LC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis, 189, p. 113464.
  33. Hu, S. and D’Argenio, D.Z., 2020. Predicting monoclonal antibody pharmacokinetics following subcutaneous administration via whole-body physiologically-based modeling.  Journal of Pharmacokinetics and Pharmacodynamics, 47, pp. 385-409.
  34. Hua, X., Li, C., Pogue, J.M., Sharma, V.S., Karaiskos, I., Kaye, K.S., Tsuji, B.T., Bergen, P.J., Zhu, Y., Song, J. and Li, J., 2020. ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study. JMIR mHealth and uHealth, 8(12), p. e20525.
  35. Jaisue, S., Pongsakul, C., D’Argenio, D.Z. and Sermsappasuk, P., 2020. Population Pharmacokinetic Modeling of Vancomycin in Thai Patients with Heterogeneous and Unstable Renal Function. Therapeutic drug monitoring, 42(6), p. 856.
  36. Jankowska, A., Satała, G., Kołaczkowski, M., Bucki, A., Głuch-Lutwin, M., Świerczek, A., Pociecha, K., Partyka, A., Jastrzębska-Więsek, M., Lubelska, A. and Latacz, G., 2020. Novel anilide and benzylamide derivatives of arylpiperazinylalkanoic acids as 5-HT1A/5-HT7 receptor antagonists and phosphodiesterase 4/7 inhibitors with procognitive and antidepressant activity. European Journal of Medicinal Chemistry, 201, p. 112437.
  37. Jimenez-Toro, I., Rodriguez, C.A., Zuluaga, A.F., Otalvaro, J.D. and Vesga, O., 2020. A new pharmacodynamic approach to study antibiotic combinations against enterococci in vivo: Application to ampicillin plus ceftriaxone.  Plos one, 15(12), p. e0243365.
  38. Jones, R.S., Parker, M.D. and Morris, M.E., 2020. Monocarboxylate Transporter 6-Mediated Interactions with Prostaglandin F2α: In Vitro and In Vivo Evidence Utilizing a Knockout Mouse Model. Pharmaceutics, 12(3), p. 201.
  39. Jones, R.S., Ruszaj, D., Parker, M.D. and Morris, M.E., 2020. Contribution of Monocarboxylate Transporter 6 to the Pharmacokinetics and Pharmacodynamics of Bumetanide in Mice. Drug Metabolism and Disposition, 48(9), pp. 788-795.
  40. Johnson, A., McEntee, L., Farrington, N., Kolamunnage-Dona, R., Franzoni, S., Vezzelli, A., Massimiliano, M., Knechtle, P., Belley, A., Dane, A. and Drusano, G., 2020. Pharmacodynamics of cefepime combined with the novel extended-spectrum-β-lactamase (ESBL) inhibitor enmetazobactam for murine pneumonia caused by ESBL-producing Klebsiella pneumoniae.  Antimicrobial Agents and Chemotherapy, 64(6).
  41. Kaminskas, L.M., Landersdorfer, C.B., Bischof, R.J., Leong, N., Ibrahim, J., Davies, A.N., Pham, S., Beck, S., Montgomery, A.B. and Surber, M.W., 2020. Aerosol pirfenidone pharmacokinetics after inhaled delivery in sheep: a viable approach to treating idiopathic pulmonary fibrosis.  Pharmaceutical research, 37(1), pp. 1-11.
  42. Kim, M.S. and Baek, I.H., 2020. Pharmacokinetic analysis of mosapride following intravenous and oral administration in beagle dogs.  Journal of Veterinary Pharmacology and Therapeutics, 43(5), pp. 454-460.
  43. Li, X., DuBois, D.C., Almon, R.R. and Jusko, W.J., 2020. Physiologically Based Pharmacokinetic Modeling Involving Nonlinear Plasma and Tissue Binding: Application to Prednisolone and Prednisone in Rats. Journal of Pharmacology and Experimental Therapeutics, 375(2), pp.385-396.
  44. Li, Z., Huisman, M. and Shah, D.K., 2020. Validation of the Platform PBPK Model for Antibodies Using Preclinical and Clinical Biodistribution Data Generated With 89Zr Labeled Molecules. Towards Development of Systems Pharmacokinetic Models for Protein Therapeutics, p.251.
  45. Li, Z., Yu, X., Li, Y., Chang, H.P. and Shah, D.K., 2020. A Two-Pore Physiologically-Based Pharmacokinetic Model for Subcutaneous Absorption of Protein Therapeutics. Towards Development of Systems Pharmacokinetic Models for Protein Therapeutics, p.251.
  46. Lim, T.P., Teo, J.Q.M., Goh, A.W.L., Tan, S.X., Koh, T.H., Lee, W.H.L., Cai, Y., Tan, T.T. and Kwa, A.L.H., 2020. In Vitro Pharmacodynamics of Fosfomycin against Carbapenem-Resistant Enterobacter cloacae and Klebsiella aerogenes. Antimicrobial agents and chemotherapy, 64(9).
  47. Lin, Y.W., Chang, R.Y., Rao, G.G., Jermain, B., Han, M.L., Zhao, J.X., Chen, K., Wang, J.P., Barr, J.J., Schooley, R.T. and Kutter, E., 2020. Pharmacokinetics/pharmacodynamics of antipseudomonal bacteriophage therapy in rats: a proof-of-concept study. Clinical Microbiology and Infection, 26(9), pp.1229-1235.
  48. Liu, Q., Bi, G., Chen, G., Guo, X., Tu, S., Tong, X., Xu, M., Liu, M., Wang, B., Jiang, H. and Wang, J., 2020. Time-dependent Distribution of Hydroxychloroquine in Cynomolgus Macaques using Population Pharmacokinetic Modelling Method. Frontiers in Pharmacology, 11, p.2099.
  49. Liu, X., Yousef, S., Anissimov, Y.G., van der Hoek, J., Tsakalozou, E., Ni, Z., Grice, J.E. and Roberts, M.S., 2020. Diffusion modelling of percutaneous absorption kinetics. Predicting urinary excretion from in vitro skin permeation tests (IVPT) for an infinite dose. European Journal of Pharmaceutics and Biopharmaceutics, 149, pp.30-44.
  50. Lodise Jr, T.P., Rosenkranz, S.L., Finnemeyer, M., Evans, S., Sims, M., Zervos, M.J., Creech, C.B., Patel, P.C., Keefer, M., Riska, P. and Silveira, F.P., 2020. The Emperor’s New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among Adult Hospitalized Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE). Clinical Infectious Diseases, 70(8), pp.1536-1545.
  51. Mallikaarjun, S., Chapagain, M.L., Sasaki, T., Hariguchi, N., Deshpande, D., Srivastava, S., Berg, A., Hirota, K., Inoue, Y., Matsumoto, M. and Hafkin, J., 2020. Cumulative fraction of response for once-and twice-daily delamanid in patients with pulmonary multidrug-resistant tuberculosis. Antimicrobial Agents and Chemotherapy, 65(1).
  52. Miao, X., Bu, R., Liu, Y., Li, B., Zhang, X., Xing, H. and Li, G., 2020. An Integrated TK-TD Model for Evaluation of Radix Aconitikusnezoffii (RAK). Pharmacology, pp.1-12.
  53. Nguyen, V.A. and Ramanathan, M., 2020. Pharmacodynamic modeling of synergistic birinapant/paclitaxel interactions in pancreatic cancer cells. Journal of Pharmacokinetics and Pharmacodynamics, 47(6), pp. 561-572.
  54. Niu, J., Wang, X., Qu, J., Mager, D.E. and Straubinger, R.M., 2020. Application of Brunauer–Emmett–Teller (BET) theory and the Guggenheim–Anderson–de Boer (GAB) equation for concentration-dependent, non-saturable cell–cell interaction dose-responses. BMC cancer, 20(1), pp.1-19.
  55. Onufrak, N.J., Smith, N.M., Satlin, M.J., Bulitta, J.B., Tan, X., Holden, P.N., Nation, R.L., Li, J., Forrest, A., Tsuji, B.T. and Bulman, Z.P., 2020. In pursuit of the triple crown: mechanism-based pharmacodynamic modelling for the optimization of three-drug combinations against KPC-producing Klebsiella pneumoniae. Clinical Microbiology and Infection, 26(9), pp.1256-e1.
  56. Ozdin, D., Kanfer, I. and Ducharme, M.P., 2020. Novel Approach for the Bioequivalence Assessment of Topical Cream Formulations: Model-Based Analysis of Tape Stripping Data Correctly Concludes BE and BIE. Pharmaceutical Research, 37(2), pp.1-18.
  57. Piscitelli, J., 2020. The Use of a Mechanism-Based Model (MBM) to Better Characterize the Pharmacology of Combination Colistin (COL) and Ceftazidime/Avibactam (CZA) Across Five Carbapenem-resistant Klebsiella pneumoniae Strains.
  58. Ramanathan, M., 2020. Application of Brunauer–Emmett–Teller (BET) theory and the Guggenheim–Anderson–de Boer (GAB) equation for concentration-dependent, non-saturable cell–cell interaction dose-responses. Journal of Pharmacokinetics and Pharmacodynamics, pp.1-12.
  59. Rong, Y., Jun, H. and Kiang, T.K., 2020. Population pharmacokinetics of mycophenolic acid in paediatric patients. British Journal of Clinical Pharmacology.
  60. Sabina, Š., Iztok, G., Andrej, Š., Milan, P. and Vesna, C.F., 2020. Preliminary toxicokinetic study of BPA in lactating dairy sheep after repeated dietary and subcutaneous administration. Scientific Reports (Nature Publisher Group), 10(1). Yu, R., Li, X., DuBois, D.C., Almon, R.R., Cao, Y. and Jusko, W.J., 2020. Interactions of Tofacitinib and Dexamethasone on Lymphocyte Proliferation. Pharmaceutical Research, 37(6).
  61. Sharma, A., Li, M., Thavathiru, E., Ibrahim, M., Garcia-Contreras, L., Benbrook, D.M. and Woo, S., 2020. Physiologically Based Pharmacokinetic Modeling and Tissue Distribution Characteristics of SHetA2 in Tumor-Bearing Mice. The AAPS journal, 22(2), pp.1-12.
  62. Sharma, S., Li, Z., Bussing, D. and Shah, D.K., 2020. Evaluation of Quantitative Relationship Between Target Expression and Antibody-Drug Conjugate Exposure Inside Cancer Cells. Drug Metabolism and Disposition, 48(5), pp.368-377.
  63. Shin, S., Kim, T.H., Chung, S.E., Lee, J.B., Kim, D.H. and Shin, B.S., 2020. Development of a population pharmacokinetics-based in vitro-in vivo correlation model for drugs with site-dependent absorption: The acyclovir case study. The AAPS journal, 22(2), pp.1-12.
  64. Smith, N.M., Lenhard, J.R., Boissonneault, K.R., Landersdorfer, C.B., Bulitta, J.B., Holden, P.N., Forrest, A., Nation, R.L., Li, J. and Tsuji, B.T., 2020. Using machine learning to optimize antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii. Clinical Microbiology and Infection, 26(9), pp.1207-1213.
  65. Šturm, S., Grabnar, I., Škibin, A., Pogačnik, M. and Cerkvenik-Flajs, V., 2020. Preliminary toxicokinetic study of BPA in lactating dairy sheep after repeated dietary and subcutaneous administration. Scientific reports, 10(1), pp.1-9.
  66. Srivastava, S., Deshpande, D., Magombedze, G., van Zyl, J., Cirrincione, K., Martin, K., Bendet, P., Berg, A., Hanna, D., Romero, K. and Hermann, D., 2020. Duration of pretomanid/moxifloxacin/pyrazinamide therapy compared with standard therapy based on time-to-extinction mathematics. Journal of Antimicrobial Chemotherapy, 75(2), pp.392-399.
  67. Srivastava, S., van Zyl, J., Cirrincione, K., Martin, K., Thomas, T., Deshpande, D., Alffenaar, J.W., Seddon, J.A. and Gumbo, T., 2020. Evaluation of ceftriaxone plus avibactam in an intracellular hollow fiber model of tuberculosis: implications for the treatment of disseminated and meningeal tuberculosis in children. The Pediatric infectious disease journal, 39(12), p. 1092.
  68. Šturm, S., Grabnar, I., Škibin, A., Pogačnik, M. and Cerkvenik-Flajs, V., 2020. preliminary toxicokinetic study of BpA in lactating dairy sheep after repeated dietary and subcutaneous administration. Scientific reports, 10(1), pp.1-9.
  69. Świerczek, A., Pociecha, K., Ślusarczyk, M., Chłoń-Rzepa, G., Baś, S., Mlynarski, J., Więckowski, K., Zadrożna, M., Nowak, B. and Wyska, E., 2020. Comparative Assessment of the New PDE7 Inhibitor–GRMS-55 and Lisofylline in Animal Models of Immune-Related Disorders: A PK/PD Modeling Approach. Pharmaceutical research, 37(2), pp.1-21.
  70. Tewes, F., Brillault, J., Gregoire, N., Olivier, J.C., Lamarche, I., Adier, C., Healy, A.M. and Marchand, S., 2020. Comparison between Colistin Sulfate Dry Powder and Solution for Pulmonary Delivery. Pharmaceutics, 12(6), p.557.
  71. Tam, V.H., Lee, L.S., Ng, T.M., Lim, T.P., Cherng, B.P., Adewusi, H., Hee, K.H., Ding, Y., Chung, S.J., Ling, L.M. and Chlebicki, P., 2020. Performance of Population Pharmacokinetic Models in Predicting Polymyxin B Exposures. Microorganisms, 8(11), p.1814.
  72. Valdivia, S.O., Montesinos, R.N., Vera, K. and Dávila-del-Carpio, G., 2020. Usability Experience in the Calculation of Pharmacokinetic Parameters With Software: Phenytoin Case. 
  73. Weiss, M. and Siegmund, W., 2020. Unusual Distribution Kinetics of Gadoxetate in Healthy Human Subjects Genotyped for OATP1B1: Application of Population Analysis and a Minimal Physiological‐Based Pharmacokinetic Model. The Journal of Clinical Pharmacology.
  74. Yamada, W.M., Neely, M.N., Bartroff, J., Bayard, D.S., Burke, J.V., van Guilder, M., Jelliffe, R.W., Kryshchenko, A., Leary, R., Tatarinova, T. and Schumitzky, A., 2020. An algorithm for nonparametric estimation of a multivariate mixing distribution with applications to population pharmacokinetics.  ThePharmaceutics, 13(1), p. 42.
  75. Yu, R., Li, X., DuBois, D.C., Almon, R.R., Cao, Y. and Jusko, W.J., 2020. Interactions of Tofacitinib and Dexamethasone on Lymphocyte Proliferation. Pharmaceutical Research, 37(6).
  76. Zhong, B., Campagne, O., Tinkle, C.L. and Stewart, C.F., 2020. An LC/ESI–MS/MS method to quantify the PI3K inhibitor GDC‐0084 in human plasma and cerebrospinal fluid: Validation and clinical application. Biomedical Chromatography, 34(1), p.e4697.